Business
OnKure Therapeutics to Participate in Upcoming Investor Conferences
BOULDER, Colo., Nov. 04, 2025 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines, today announced that Nichoals Saccomano, Ph.D., President and Chief Executive Officer, will present and be available for one-on-one investor meetings at the following investor conferences: A fireside chat at the Guggenheim Healthcare Innovation Conference, in Boston on Monday, November 10, 2025, at 4:00 p.m
About this update from Onkure Therapeutics, Inc.
[{"type":"image","alt":"OnKure Therapeutics, Inc.","displaySize":"","headline":null,"caption":"OnKure Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":150,"url":"https://media.zenfs.com/en/globenewswire.com/80a75f50988a3e7732dc404944bce001"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/lmQIfegLNApEkytHgGTsoQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/80a75f50988a3e7732dc404944bce001","width":300,"height":150}},"lazy":false},{"type":"text","content":"BOULDER, Colo., Nov. 04, 2025 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines, today announced that Nichoals Saccomano, Ph.D., President and Chief Executive Officer, will present and be available for one-on-one investor meetings at the following investor conferences:","length":380,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"A fireside chat at the Guggenheim Healthcare Innovation Conference, in Boston on Monday, November 10, 2025, at 4:00 p.m. ET. A live audio webcast will be available through this link. ","length":182,"tagName":"p"}]},{"val":[{"type":"text","content":"A corporate presentation at the Stifel Healthcare Conference, in New York on November 12, 2025, at 4:00 p.m. ET. A live audio webcast will be available through this link.","length":170,"tagName":"p"}]},{"val":[{"type":"text","content":"A fireside chat at the Evercore Healthcare Conference, in Miami on December 3, 2025, at 12:30 p.m. ET. A live audio webcast will be available through this link.","length":160,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":512,"olType":false},{"type":"text","content":"Following the events, replays will be available on the OnKure website (click here) for 30 days.","length":100,"tagName":"p"},{"type":"text","content":"About OnKure Therapeutics","length":25,"tagName":"p"},{"type":"text","content":"OnKure Therapeutics, Inc. (Nasdaq: OKUR) is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. Using a structure-based drug design platform, OnKure is building a pipeline of tumor-agnosti...